Biodexa Pharmaceuticals Files 6-K Report
Ticker: BDRX · Form: 6-K · Filed: Jun 4, 2025 · CIK: 1643918
| Field | Detail |
|---|---|
| Company | Biodexa Pharmaceuticals PLC (BDRX) |
| Form Type | 6-K |
| Filed Date | Jun 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
Related Tickers: BDRX
TL;DR
Biodexa Pharma (BDRX) filed a 6-K, standard reporting for foreign issuers.
AI Summary
Biodexa Pharmaceuticals PLC filed a Form 6-K on June 4, 2025, to report information for the month of June 2025. The company, formerly known as Midatech Pharma Plc, is a foreign private issuer and files annual reports under Form 20-F. Its principal executive office is located at 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ, United Kingdom.
Why It Matters
This filing provides routine updates for Biodexa Pharmaceuticals PLC as a foreign private issuer, indicating ongoing compliance and reporting activities.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain new material financial or operational information that would typically increase risk.
Key Players & Entities
- Biodexa Pharmaceuticals PLC (company) — Registrant
- Midatech Pharma Plc (company) — Former company name
- June 4, 2025 (date) — Filing date
- 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ, United Kingdom (location) — Principal executive office address
- 001-37652 (other) — Commission File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC that the issuer makes or is required to make public in its home country.
What is Biodexa Pharmaceuticals PLC's former name?
Biodexa Pharmaceuticals PLC was formerly known as Midatech Pharma Plc, with a date of name change on June 2, 2015.
Where is Biodexa Pharmaceuticals PLC's principal executive office located?
The principal executive office of Biodexa Pharmaceuticals PLC is located at 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ, United Kingdom.
Does Biodexa Pharmaceuticals PLC file under Form 20-F?
Yes, Biodexa Pharmaceuticals PLC indicates by check mark that it files annual reports under cover of Form 20-F.
What is the Commission File Number for Biodexa Pharmaceuticals PLC?
The Commission File Number for Biodexa Pharmaceuticals PLC is 001-37652.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 4, 2025 regarding Biodexa Pharmaceuticals Plc (BDRX).